1. Home
  2. PR vs RDY Comparison

PR vs RDY Comparison

Compare PR & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Permian Resources Corporation

PR

Permian Resources Corporation

HOLD

Current Price

$20.37

Market Cap

17.6B

Sector

Energy

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$13.06

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PR
RDY
Founded
2015
1984
Country
United States
India
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.6B
11.6B
IPO Year
2016
2001

Fundamental Metrics

Financial Performance
Metric
PR
RDY
Price
$20.37
$13.06
Analyst Decision
Buy
Strong Buy
Analyst Count
18
1
Target Price
$22.19
$16.90
AVG Volume (30 Days)
12.1M
2.2M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
3.19%
0.55%
EPS Growth
N/A
N/A
EPS
1.28
N/A
Revenue
$5,065,211,000.00
N/A
Revenue This Year
$16.52
$7.81
Revenue Next Year
$8.35
$3.20
P/E Ratio
$15.68
$18.67
Revenue Growth
1.29
N/A
52 Week Low
$11.44
$12.82
52 Week High
$21.99
$16.17

Technical Indicators

Market Signals
Indicator
PR
RDY
Relative Strength Index (RSI) 53.19 39.25
Support Level $19.26 $12.93
Resistance Level $21.99 $14.14
Average True Range (ATR) 0.66 0.25
MACD -0.22 -0.02
Stochastic Oscillator 40.48 20.83

Price Performance

Historical Comparison
PR
RDY

About PR Permian Resources Corporation

Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization, and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: